TOP TIERMARKET NEWSWIRE
News & sentiment

KODIAK SCIENCES INC (KOD) — News & AI sentiment

KODIAK SCIENCES INC (KOD) news roundup. 12 stories aggregated over the last 30 days. Average 30-day sentiment is 58.3/100. Recent insider activity (SEC Form 4, 90-day window): 3 purchases totalling $157.0M and 1 sales totalling $2.7M — net buying of $154.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
12
avg sentiment 58.3/100
Insider net (90d)
$154.3M
3 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

KOD news in the last 24 hours, 7 days, 30 days and 90 days

How much KOD coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowKOD storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1258.3/100KOD headlines →
Last 90 days6859.7/100KOD headlines →

Latest stories on KOD

Oct 28
Oct 22
Oct 20
Oct 20
Oct 20
Oct 14
Oct 14
H.C. Wainwright raises Kodiak Sciences stock price target on trial data
Investing.com Analyst Ratings64 · neutralanalyst
Oct 12
Oct 12
Oct 10
Oct 7
Oct 7
Oct 5
Oct 4
Oct 1
Oct 1
Why is Kodiak Sciences stock rallying today?
Investing.com Markets50 · neutralgeneral
Oct 1
Sep 30
Sep 30
Sep 29
Sep 29
Sep 29
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Stocktwits News73 · bullishearnings
Sep 29
Why Kodiak Sciences Skyrocketed Today
The Motley Fool73 · bullishproduct/pr
Sep 29
Sep 28
Open KOD in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →